PRISM BioLab Co., Ltd. – Trademark Portfolio
Entity Type: 03
PRISM BioLab Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PEPMETICS. The owner is based in Fujisawa-shi, Kanagawa.
26-1, Muraoka-Higashi 2-chome
Fujisawa-shi, Kanagawa 251-0012 , JP
Showing of trademarks Trademarks
Trademark Classifications
PRISM BioLab Co., Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does PRISM BioLab Co., Ltd. have?
PRISM BioLab Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does PRISM BioLab Co., Ltd. file in?
PRISM BioLab Co., Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are PRISM BioLab Co., Ltd.'s most well-known trademarks?
PRISM BioLab Co., Ltd.'s registered trademark portfolio includes well-known marks such as PEPMETICS. These are among 1 currently registered trademark in the portfolio.
What is PRISM BioLab Co., Ltd.'s trademark registration success rate?
PRISM BioLab Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.